US 12311026
Therapeutic uses for sodium thiosulfate formulations
granted A61KA61K33/04A61K33/243
Quick answer
US patent 12311026 (Therapeutic uses for sodium thiosulfate formulations) held by Fennec Pharmaceuticals, Inc. expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fennec Pharmaceuticals, Inc.
- Grant date
- Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K33/04, A61K33/243, A61K47/02, A61K47/18